News

Long term use of once-nightly sodium oxybate is well-tolerated among patients with narcolepsy type 1 or 2 with primarily mild adverse reactions.
Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...
Tylenol has been linked with half of all acute liver failure cases in the U.S. Doctors now warn that it's the most dangerous ...
Now, a new evidence review has identified the most effective treatments for people who suffer from chronic hives.
Stephanie Nixdorf's insurance company declined to cover a drug to treat her arthritis. That changed after she sent an appeal ...
EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare gene ...
The FDA plays a crucial role in safeguarding public health by monitoring the safety of products. Recently, two significant ...
The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.
Five months after taking over the federal agency responsible for the health of all Americans, Robert F. Kennedy Jr. wants to ...
The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.
A massive global study has ranked the best and safest treatments for chronic hives when antihistamines fall short. The ...